University of Florida, College of Veterinary Medicine, Gainesville, Florida, USA.
Tufts University, Cummings School of Veterinary Medicine, North Grafton, Massachusetts, USA.
J Vet Intern Med. 2021 Mar;35(2):771-779. doi: 10.1111/jvim.16075. Epub 2021 Feb 27.
Associations of diet with dilated cardiomyopathy are under investigation.
That cardiac assessment would show abnormalities in healthy dogs eating grain-free (GF) diets or diets with Food and Drug Administration (FDA)-listed ingredients of concern (peas, lentils, or potatoes) as top 10 ingredients (FDA-PLP), but not in dogs eating grain-inclusive (GI) diets or diets without FDA-listed ingredients of concern (PLP) in the top 10 ingredients (NoFDA-PLP).
One hundred eighty-eight healthy Doberman Pinschers, Golden Retrievers, Miniature Schnauzers, and Whippets.
This study was an observational cross-sectional study. Echocardiograms, cardiac biomarkers, and blood and plasma taurine concentrations were compared between dogs eating GF (n = 26) and GI (n = 162) diets, and between FDA-PLP (n = 39) and NoFDA-PLP (n = 149) diets, controlling for age and breed. Demographic characteristics, murmurs, genetic status, and ventricular premature complexes (VPCs) during examination were compared between dogs eating different diet types.
No differences in echocardiographic variables, N-terminal pro-B-type natriuretic peptide or whole blood taurine were noted between dogs eating different diet types. Dogs eating GF diets had higher median high-sensitivity cardiac troponin I (hs-cTnI) (GF 0.076 ng/mL [Interquartile range (IQR), 0.028-0.156] vs. GI 0.048 [IQR, 0.0026-0.080]; P < .001) and higher median plasma taurine (GF 125 nmol/mL [IQR, 101-148] vs GI 104 [IQR, 86-123]; P = .02) than dogs eating GI diets. Dogs eating FDA-PLP diets had higher median hs-cTnI (0.059 ng/mL [IQR, 0.028-0.122]) than dogs eating NoFDA-PLP diets (0.048 [IQR, 0.025-0.085]; P = .006). A greater proportion of dogs eating FDA-PLP diets (10%) had VPCs than dogs eating NoFDA-PLP diets (2%; P = .04).
Higher hs-cTnI in healthy dogs eating GF and FDA-PLP diets might indicate low-level cardiomyocyte injury.
人们正在研究饮食与扩张型心肌病之间的关系。
心脏评估将显示食用无谷(GF)饮食或含有美国食品和药物管理局(FDA)列出的关注成分(豌豆、扁豆或土豆)作为前 10 种成分(FDA-PLP)的健康犬的心脏异常,但食用含谷物(GI)饮食或前 10 种成分中没有 FDA 列出的关注成分(PLP)的犬没有异常(NoFDA-PLP)。
188 只健康的杜宾犬、金毛寻回犬、迷你雪纳瑞犬和惠比特犬。
这是一项观察性的横断面研究。通过比较食用 GF(n=26)和 GI(n=162)饮食的犬,以及食用 FDA-PLP(n=39)和 NoFDA-PLP(n=149)饮食的犬之间的超声心动图、心脏生物标志物以及血液和血浆牛磺酸浓度,控制年龄和品种。比较食用不同饮食类型的犬之间的人口统计学特征、杂音、遗传状况和检查期间的室性期前收缩(VPC)。
食用不同饮食类型的犬之间的超声心动图变量、N 端脑利钠肽前体或全血牛磺酸无差异。食用 GF 饮食的犬的中位高敏心肌肌钙蛋白 I(hs-cTnI)较高(GF 0.076ng/mL[四分位距(IQR),0.028-0.156] vs.GI 0.048ng/mL[IQR,0.0026-0.080];P<0.001),血浆牛磺酸中位值较高(GF 125nmol/mL[IQR,101-148] vs.GI 104nmol/mL[IQR,86-123];P=0.02),高于食用 GI 饮食的犬。食用 FDA-PLP 饮食的犬的中位 hs-cTnI(0.059ng/mL[IQR,0.028-0.122])高于食用 NoFDA-PLP 饮食的犬(0.048ng/mL[IQR,0.025-0.085];P=0.006)。食用 FDA-PLP 饮食的犬中有更大比例(10%)出现 VPC,高于食用 NoFDA-PLP 饮食的犬(2%;P=0.04)。
食用 GF 和 FDA-PLP 饮食的健康犬的 hs-cTnI 升高可能表明存在低水平的心肌细胞损伤。